Mammalian target of rapamycin complex 2 (mTORC2) phosphorylates AGC protein kinases including protein kinase C (PKC) and regulates cellular functions such as cell migration. However, its regulation remains poorly understood. Here we show that lysophosphatidic acid (LPA) induces two phases of PKC-δ hydrophobic motif phosphorylation. The late phase is mediated by Gα 12 , which specifically activates ARAF, leading to upregulation of the RFFL E3 ubiquitin ligase and subsequent ubiquitylation and degradation of the PRR5L subunit of mTORC2. Destabilization of PRR5L, a suppressor of mTORC2-mediated hydrophobic motif phosphorylation of PKC-δ, but not AKT, results in PKC-δ hydrophobic motif phosphorylation and activation. This Gα 12 -mediated signalling pathway for mTORC2 regulation is critically important for fibroblast migration and pulmonary fibrosis development.
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mTOR is an evolutionarily conserved serine or threonine protein kinase. It plays an important role in regulating a wide range of cell activities in response to extracellular stimuli [1] [2] [3] [4] [5] . This kinase is present in two structurally and functionally distinct protein complexes, mTORC1 and mTORC2. These two complexes share two common components, MLST8 (GβL) and DEPTOR, but other components are distinct. Whereas mTORC1 has RAPTOR and PRAS40 (refs 6-10), mTORC2 contains RICTOR (RPTOR independent companion of mTOR, complex 2), MAPKAP1 (mitogen-activated protein kinase associated protein 1, also known as SIN1) and PRR5 and PRR5L (proline rich 5 and proline rich 5 like, also known as Protor-1 and 2; refs [11] [12] [13] [14] [15] . The molecular functions of these mTORC components remain poorly defined. Nevertheless, studies suggest that MLST8, RICTOR, RAPTOR and MAPKAP1 are critical for the complex assembly and/or linking the mTOR kinase to its substrates 3, 4 . The function of PPR5L is not known.
The two mTOR complexes are regulated differently. Whereas mTORC1 regulates diverse cellular processes including protein synthesis, ribosome biogenesis, transcription and autophagy [16] [17] [18] [19] , mTORC2 regulates AGC kinases, including AKT and PKC, by phosphorylating their hydrophobic motif sites [20] [21] [22] [23] [24] . mTORC2 also phosphorylates turn motifs of AKT and PKC, but this phosphorylation is independent of growth factor regulation 20, 22 . The cellular activities that mTORC2 regulates include actin cytoskeleton reorganization and cell migration 13, 23, [25] [26] [27] . Many extracellular stimuli, including growth factors, G protein-coupled receptor ligands and cytokines, stimulate AKT and PKC hydrophobic motif phosphorylation. The phosphoinositide 3-kinase-mediated regulation of AKT hydrophobic motif phosphorylation was initially attributed to PtdIns(3,4,5)P 3mediated membrane translocation and conformational changes of AKT. However, recent evidence suggests that the mTORC2 kinase may also be regulated by PtdIns (3, 4, 5 )P 3 directly [28] [29] [30] and indirectly through stimulation of its ribosome association 31 . Ribosome-associated mTORC2 promotes cotranslational phosphorylation of AKT turn motif and stability of nascent AKT polypeptides 32 . It is not known whether there are other mechanisms for extracellular stimuli to regulate mTORC2 or whether mTORC2's activity toward different substrates can be selectively regulated.
In our recent study of mTORC2 kinase activity regulation by PtdIns(3,4,5)P 3 (ref. 30) , we discovered that Gα 12 , but not Gα 13 , specifically regulated PKC-δ hydrophobic motif phosphorylation in HEK293T and mouse embryonic fibroblasts (MEFs). This led us to uncovering a signalling mechanism by which LPA, through Gα 12 and mTORC2, stimulates long term PKC-δ hydrophobic motif phosphorylation and activation, which is important for fibroblast migration and pulmonary fibrosis development.
RESULTS

Persistent PKC activation by LPA and Gα 12
In our recent study of mTORC2 regulation, we found that expression of the activated Glu-Leu (QL) form of Gα 12 , but not that of Gα i2 , Gα 13 , Gα oA or Gα 11 , in HEK293T cells stimulated hydrophobic motif phosphorylation of PKC-δ (pHM-PKC-δ), but not AKT ( Fig. 1a and Supplementary Fig. S1a ). Expression of Gα QL 12 could also increase PKC phosphorylation detected by an antibody recognizing the hydrophobic motif phosphorylation of all of the PKC isoforms (pHM-pan-PKC) and myristoylated alanine-rich protein kinase C substrate (MARCKS) phosphorylation (Fig. 1a ). Because MARCKS phosphorylation could be blocked by a PKC inhibitor ( Supplementary Fig. S1b ), it is a surrogate marker for PKC activity.
LPA, which can signal through the Gα 12 or Gα 13 family of G proteins 33, 34 , also stimulated PKC-δ hydrophobic motif and MARCKS phosphorylation in HEK293T cells ( Supplementary Fig. S1c ) or MEFs ( Fig. 1b ) with two phases: an early phase response peaked before 5 min, and a late one after 1 h of stimulation. On the other hand, LPA induced only one phase of AKT hydrophobic motif phosphorylation that peaked before 5 min of the stimulation ( Fig. 1b and Supplementary Fig. S1c ). The late, but not the early, phase PKC hydrophobic motif phosphorylation depended on Gα 12 as determined using Gα 12 -null (Gna12 −/− ) MEFs (Fig. 1c ). Importantly, expression of Gα 12 in Gna12 −/− MEFs restored the late phase stimulation by LPA ( Fig. 1c ). Gα 13 deficiency, however, had no significant effects on either phase of PKC hydrophobic motif or MARCKS phosphorylation ( Supplementary Fig. S1d ; data not shown), suggesting that LPA acts primarily through Gα 12 to induce late phase PKC hydrophobic motif and MARCKS phosphorylation. Furthermore, LPA seemed to act largely through the type 1 LPA receptor to stimulate the late phase responses ( Supplementary Fig. S1e ).
PRR5L ubiquitylation and destabilization
PKC hydrophobic motif phosphorylation may be mediated by mTORC2 (refs 3,4) . We thus knocked down the gene encoding an mTORC2 core component, MAPKAP1, which caused a strong inhibition of the late, but not the early, phase PKC-δ hydrophobic motif and MARCKS phosphorylation in response to LPA, while abrogating AKT hydrophobic motif phosphorylation ( Fig. 2a ). These results suggest that the two phases of PKC-δ hydrophobic motif phosphorylation may be regulated differently. Consistent with this conclusion, mTORC2 pulled down by a RICTOR antibody from wild-type (WT) MEFs treated with LPA for 120 min, but not from those treated for 1 min, showed increased ability to phosphorylate PKC in an in vitro kinase assay ( Supplementary Fig. S2a ). Of note, mTORC2 from the long term LPA treatment did not stimulate AKT hydrophobic motif phosphorylation ( Supplementary Fig. S2a ). Because PKC could autophosphorylate its hydrophobic motif site ( Supplementary Fig. S2b ), the early phase PKC hydrophobic motif phosphorylation may be due to autophosphorylation, probably as the result of PKC activation by LPA through phospholipase C (ref. 35) .
To understand how LPA may induce the late phase PKC-δ hydrophobic motif phosphorylation through mTORC2, we examined Gα QL : Lz o i 12 11 13
Gna12 -/-MEF
Figure 1
Gα 12 is required for LPA-induced late phase PKC hydrophobic motif phosphorylation and activation. (a) Gα QL 12 , but not other Gα QL subunits, stimulates PKC hydrophobic motif and MARCKS phosphorylation. HEK293T cells were transfected with one of the constitutively activated forms of Gα in the absence of serum. Cells were collected 24 h after transfection for western analysis. Normalized quantification of immunoblots was carried out from independent experiments. Data are presented as means ± s.d. the possibility that LPA treatment might alter the protein content of the mTORC2 components. Whereas LPA did not alter the content of the core mTORC2 components, including mTOR, RICTOR, MAPKAP1 and MLST8, it reduced the content of PRR5L, an mTORC2-binding protein with no clear function, in HEK293T cells (Fig. 2b) ( Supplementary Fig. S2c,d ). Expression of Gα QL 12 , but not Gα QL 13 , also led to a reduction in the protein content of PRR5L, but not other mTORC2 components ( Fig. 2c ).
LPA did not alter the PRR5L messenger RNA concentrations in HEK293T cells ( Fig. 2d ) or MEFs (data not shown), but the proteasome inhibitor MG132 inhibited LPA-induced PRR5L destabilization ( Fig. 2b) . By contrast, the lysosome inhibitor chloroquine had no effect (Fig. 2b) . These results suggest that LPA may induce destabilization of PRR5L through the proteasome, which often requires polyubiquitylation of its target proteins. Indeed, LPA treatment or Gα QL 12 expression stimulated PRR5L ubiquitylation ( Fig. 2e ).
PRR5L inhibits PKC hydrophobic motif phosphorylation
LPA failed to elicit the late phase PKC-δ hydrophobic motif phosphorylation, without noticeable effects on the early phase PKC-δ and AKT hydrophobic motif phosphorylation, in MEFs derived from Prr5 −/− ; Prr5l −/− mice (Fig. 3a ). In addition, expression of PRR5L in these Prr5 −/− ; Prr5l −/− MEFs restored the late phase ; Prr5l −/− (Prr −/− ) MEFs and those infected with PRR5L-expressing retrovirus were stimulated with LPA (400 nM). Normalized quantification of immunoblots was carried out from independent experiments. Data are presented as means±s.d. ( * P < 0.01, Student's t -test, n = 3). NS, not significant. (b) PRR5L regulates mTORC2's substrate preference. WT MEFs were transfected with a PRR5L siRNA for 72 h. Immunoprecipitation (IP) was carried out using a control antibody (IgG) or RICTOR antibody. The immunocomplexes were used to phosphorylate recombinant glutathione S-transferase (GST)-PKC-δ or GST-AKT protein in an in vitro kinase assay or to interact with the GST-PKC-δ or GST-AKT protein in a cell-free binding assay as described in 'Methods'. Normalized quantification of immunoblots was carried out from independent experiments. Data are presented as means±s.d. ( * P < 0.01 versus LacZ-transfected or vehicle treatment (Vc) controls, Student's t -test, n = 3). Uncropped images of blots are shown in Supplementary Fig. S8 . responses, apparently by reducing the basal PKC-δ hydrophobic motif phosphorylation ( Fig. 3a) . These results, together with the observation that LPA destabilizes PRR5L protein ( Fig. 2 ), suggest that PRR5L may be a suppressor of PKC hydrophobic motif phosphorylation. LPA may hence induce the late phase PKC hydrophobic motif phosphorylation by destabilizing PRR5L protein. Consistent with this hypothesis, short interfering RNA (siRNA)-mediated knockdown of PRR5L increased PKC-δ hydrophobic motif and MARCKS phosphorylation ( Supplementary Fig. S3a ).
We next examined the effect of PRR5L in a cell-free system and found that mTORC2 immunoprecipitated by the RICTOR antibody from cells transfected with the PRR5L siRNA showed increased ability to phosphorylate the PKC-δ hydrophobic motif site when compared with mTORC2 from cells transfected with a control siRNA ( Fig. 3b ). Addition of PPR5L protein inhibited PKC hydrophobic motif phosphorylation by mTORC2 ( Fig. 3b ). Furthermore, mTORC2 from PRR5L knockdown cells showed stronger interactions with PKC-δ protein than mTORC2 from the control cells ( Fig. 3b ). Addition of recombinant PRR5L protein attenuated the interactions (Fig. 3b ). Addition of a PRR5L mutant protein that lacks its amino-terminal 95 amino acids and does not bind to mTORC2 (ref. 14) did not suppress the phosphorylation or binding ( Supplementary Fig. S3b ). These effects of PRR5L siRNA transfection and protein addition are consistent with the observation that each MAPKAP1 molecule in mTORC2 immunoprecipitated from WT cells seemed to be occupied by at least one PRR5L molecule, whereas LPA treatment reduced the stoichiometry of MAPKAP1:PRR5L to below unity ( Supplementary Fig. S3c ).
Expression of the PRR5L homologue PRR5, unlike that of PRR5L, in Prr5 −/− ; Prr5l −/− MEFs did not restore the late phase PKC-δ hydrophobic motif phosphorylation, nor did it affect the early phase responses (Fig. 4a ). Moreover, PRR5 and PRR5L did not compete for binding to mTORC2 (Fig. 4b) . These results suggest that PRR5 may not share the function of PRR5L in regulating PKC phosphorylation. In contrast to the effects on PKC-δ, addition of the PRR5L protein enhanced AKT hydrophobic motif phosphorylation by and its interaction with mTORC2 ( Fig. 3b ). However, PRR5L knockdown only slightly attenuated AKT hydrophobic motif phosphorylation or interaction with mTORC2 ( Fig. 3b ), suggesting that endogenous PRR5L may have a stronger impact on PKC than AKT regulation. Given that AKT and PKC did not seem to compete for binding to mTORC2 ( Fig. 4c ), PRR5L may bind to a site on mTORC2 that affects the regulation of PKC hydrophobic motif phosphorylation more than that of AKT.
RFFL is an E3 ligase for PRR5L
Because LPA-or Gα 12 -mediated destabilization of PRR5L depended on protein synthesis ( Supplementary Fig. S4a ), LPA and Gα 12 may upregulate the expression of an E3 ubiquitin ligase that catalyses the polyubiquitylation of PRR5L. Microarray gene expression analysis revealed that LPA upregulated the expression of 846 genes more than twofold in HEK293T cells. Among these genes, there were four verified or putative E3 ligases (RFFL, TRAF6, WWP2 and RNF157 ). Quantitative real-time PCR (qrtPCR) analysis indicated that the expression of Rffl was upregulated by LPA in a Gα 12 -dependent manner ( Fig. 5a ). RFFL expression was also upregulated by Gα QL 12 , but not Gα QL 13 (Fig. 5b) . Importantly, the RFFL siRNAs reversed LPA-mediated destabilization of PRR5L and increases in PKC hydrophobic motif and MARCKS phosphorylation (Fig. 5c ). The siRNAs also inhibited LPAor Gα QL 12 -induced ubiquitylation of PRR5L ( Supplementary Fig. S4b ). Thus, RFFL may be an E3 ligase for PRR5L.
The E3 ubiquitin ligases often bind to their substrates. Indeed, RFFL and PRR5L coimmunoprecipitated in HEK293T cells ( Fig. 5d and Supplementary Fig. S4c ), and their recombinant protein interacted ( Supplementary Fig. S4d ). Furthermore, expression of RFFL, similarly to Gα QL 12 expression or LPA treatment, was able to stimulate ubiquitylation of endogenous PRR5L (Fig. 5e ), and recombinant RFFL catalysed ubiquitylation of PRR5L in an in vitro assay ( Fig. 5f ). RFFL-mediated PRR5L polyubiquitylation is ubiquitin Lys 48 linked ( Fig. 5g ) and RFFL RING domain dependent ( Supplementary Fig. S4e ). All of these results together support the conclusion that RFFL is the E3 ligase that catalyses PRR5L polyubiquitylation in response to Gα QL 12 expression or LPA treatment.
RAF regulates Rffl expression through ERK
The Gα 12 family of G proteins has been implicated in regulation of the MAP kinases 33 . Whereas expression of Gα 12 or Gα 13 stimulated p38 kinase phosphorylation, only Gα QL 12 , not Gα QL 13 , potently stimulated mitogen-activated protein-kinase kinase (MAPKK, also known as MEK) and extracellular signal-related kinase (ERK, also known as mitogen-activated protein kinase 1, MAPK1) phosphorylation ( Supplementary Fig. S5a ). LPA has been previously shown to stimulate ERK phosphorylation 36 , which we confirmed ( Supplementary Fig.  S5a ). Consistent with these results, MEK inhibitors PD98059 and U0126 inhibited LPA-induced upregulation of RFFL expression ( Supplementary Fig. S5b ) and knockdown of MEK or ERK by siRNAs blocked Gα QL 12 -induced upregulation of RFFL expression ( Fig. 6a ) and polyubiquitylation of PRR5L ( Fig. 6b ). Together with the result that overexpression of MEK1 or ERK2 stimulated RFFL expression The binding of PRR5 to mTORC2 is not affected by the presence or absence of PRR5L. HEK293 cells were transfected with PRR5-HA or PRR5L-HA in the presence or absence of RFFL. Expression of RFFL resulted in reduction in PRR5L levels. Cells were subject to anti-RICTOR immunoprecipitation (IP). (c) PKC-δ and AKT do not compete for mTORC2 binding. Anti-RICTOR immunoprecipitates from MEFs were incubated with GST-AKT1, GST-PKC-δ or both, and bound AKT1 or PKC-δ were detected by western analysis. Uncropped images of blots are shown in Supplementary Fig. S8 .
( Supplementary Fig. S5c ) and polyubiquitylation of PRR5L ( Fig. 6c ), we concluded that LPA and Gα 12 upregulated RFFL expression through a MEK-ERK pathway.
The RAF protein kinases act upstream of MEK. Knockdown of ARAF, but not BRAF or CRAF, by siRNAs inhibited Gα QL 12 -mediated upregulation of RFFL expression and polyubiquitylation of PRR5L ( Fig. 6a,b ). Knockdown of ARAF also blocked LPA-or Gα QL 12 -induced increases in MEK, ERK and PKC-δ hydrophobic motif phosphorylation ( Supplementary Fig. S5d ), whereas knockdown of MEK blocked Gα QL 12 -induced increases in ERK and PKC-δ hydrophobic motif phosphorylation ( Supplementary Fig. S5e ). Furthermore, LPA treatment or Gα QL 12 expression increased ARAF phosphorylation ( Fig. 6d ) and ARAF expression increased RFFL expression ( Supplementary Fig. S5c ), ERK phosphorylation ( Supplementary Fig. S5e ) and PRR5L polyubiquitylation ( Fig. 6c ). Because expression of a dominant negative mutant of H-Ras, one of the upstream regulators of the Raf proteins, did not significantly inhibit LPA-mediated RFFL expression or ERK phosphorylation ( Supplementary Figs S5b,f) , we examined whether Gα 12 could interact with ARAF. Gα QL 12 and ARAF co-immunoprecipitated in HEK293T cells ( Fig. 6e ). By contrast, coimmunoprecipitation of Gα QL 12 with CRAF or of Gα QL 13 with ARAF or CRAF was not strongly detected ( Fig. 6e ), suggesting that Gα 12 may preferentially activate ARAF. Moreover, recombinant Gα 12 protein directly interacted with ARAF, but not CRAF, in a GTP-dependent manner (Fig. 6f ). All of these results indicate that LPA acts preferentially through Gα 12 to regulate RFFL expression, PRR5L polyubiquitylation and PKC-δ hydrophobic motif phosphorylation through an ARAF-MEK-ERK pathway.
Role of Gα 12 -PKC-δ in fibroblast cell migration
LPA is a potent stimulator of fibroblast migration 35 , and its effect on MEF migration depended on Gα 12 , because it failed to stimulate Gna12 −/− MEF migration ( Supplementary Fig. S6a ). Expression of Gα 12 in Gna12 −/− MEFs restored their ability to migrate in response to LPA ( Supplementary Fig. S6b) HEK293T cells were transfected with Gα QL 12 or treated with LPA (5 µM, 2 h), followed by immunoblotting. Vc, vehicle treatment. (e) Gα 12 interacts with ARAF. HEK293T cells were transfected with the plasmids as indicated. Immunoprecipitation (IP) was carried out using a Gα 12 or Gα 13 antibody in the presence of aluminium magnesium fluoride as described in 'Methods'. (f) Recombinant Gα 12 interacts with ARAF, but not CRAF, in a GTP-dependent manner. Uncropped images of blots are shown in Supplementary Fig. S8 .
PKC-δ hydrophobic motif and MARCKS phosphorylation (Fig. 1c) . Moreover, knockdown of RFFL inhibited LPA-induced MEF migration ( Fig. 7a-c) , whereas RFFL expression ( Fig. 7d ,e) or PRR5L knockdown ( Fig. 7f ) stimulated MEF migration. These results together indicate that Gα 12 -mediated upregulation of RFFL and destabilization of PRR5L are important for cell migration in response to LPA. Although PRR5 and PRR5L deficiency abrogated LPA-induced migration, expression of PRR5L, but not PRR5, restored the LPA response by suppressing the basal migration of Prr5 −/− ;Prr5l −/− MEFs (Fig. 7g ). This is consistent with our conclusion that LPA destabilizes PRR5L to induce cell migration.
To investigate the importance of PKC in MEF migration, we treated MEFs with the PKC inhibitor Gö6850 or a PKC activator phorbol myristate acetate. Whereas Gö6850 inhibited LPA-mediated MEF migration ( Supplementary Fig. S6d ), phorbol myristate acetate stimulated the migration of both WT and Gna12 −/− MEFs ( Supplementary Fig. S6e ). Moreover, knockdown of PRKCD (the gene encoding PKC-δ) inhibited MEF migration in response to LPA ( Fig. 7h and Supplementary Fig. S6f ) or PRR5L knockdown (Fig. 7f ). Expression of WT PKC-δ, but not the mutant with its hydrophobic motif site mutated (S664A), was able to restore the migration phenotype of PRKCD knockdown, indicating the importance of this phosphorylation for MEF migration (Fig. 7h ). Furthermore, expression of myristylated PKC-δ, which exhibited elevated activity (Fig. 7i ), could stimulate MEF migration even in the presence of RFFL siRNA (Fig. 7i ). These data indicate that persistent PKC-δ activation is sufficient for driving cell migration.
Role of Gα 12 in pulmonary fibrosis
Mouse genetic studies showed that Gα 12 and Gα 13 proteins functioned largely redundantly in vivo 33, 37 , but some distinct in vivo functions of Gα 13 have emerged [38] [39] [40] . Although distinct functions of Gα 12 were shown in cultured cells [41] [42] [43] , there is a lack of such evidence in vivo. The type 1 receptor of LPA, which can couple to Gα 12 , has an important role in bleomycin-induced pulmonary fibrosis primarily due to the role of LPA in fibroblast migration 44 . The involvement of Gα 12 in LPA-induced MEF migration suggests that Gα 12 deficiency should have a significant role in lung fibrosis. Indeed, Gα 12 deficiency showed significant reduction in pulmonary fibrosis (Fig. 8a,b) . Consistent with the signalling pathway delineated in cultured cells (Fig. 8c ), there were decreases in the PRRL5 protein content and increases in the levels of Rffl mRNA, accompanied by increases in ERK and PKC-δ hydrophobic motif phosphorylation, in bleomycin-treated WT ;Prr5l −/− MEFs and those infected with PRR5L-expressing retrovirus were tested in a scratch migration assay (LPA, 400 nM). Experiments were repeated three times, and a representative experiment is shown. EV, empty vector. (h) PRKCD knockdown inhibits LPA-induced MEF migration. MEFs were infected with retrovirus expressing GFP, PKC-δ and its mutant S664A, and transfected with the indicated siRNAs, followed by the scratch migration assay (LPA, 400 nM). The data are presented as means ± s.d. ( * * P < 0.05, Student's t -test, n = 3). (i) Expression of WT and myristylated PKC-δ stimulates MEF migration. MEFs were infected with retrovirus expressing WT PKC-δ, myristylated PKC-δ (Myr-PKC-δ) or myristylated PKC-δlacking the amino-terminal 280 amino acids (Myr-PKC-δ-N) and transfected with the control siRNA or RFFL siRNA. Western analysis and cell migration assay were carried out 72 h later. Experiments were repeated three times, and a representative experiment is shown. Uncropped images of blots are shown in Supplementary Fig. S8 .
lungs when compared with PBS-treated WT lungs (Fig. 8d,e ). These bleomycin-induced changes markedly diminished in Gα 12 -deficient samples (Fig. 8d,e ), suggesting that the involvement of Gα 12 in pulmonary fibrosis may be attributed to its regulation of PKC-δ hydrophobic motif phosphorylation through the signalling pathway depicted in Fig. 8c . Consistent with this conclusion, the proteasome inhibitor Bortezomib 45 or mTOR inhibitor PP242 (ref. 46 ) inhibited bleomycin-induced pulmonary fibrosis ( Supplementary Fig. S8f) , accompanied by the inhibition of PKC-δ hydrophobic motif, but not ERK, phosphorylation ( Supplementary Fig. S7a ). Importantly, Bortezomib stabilized the PRR5L protein with little effect on its mRNA level, whereas PP242 only blocked PKC-δ phosphorylation ( Supplementary Fig. S7a,b) .
DISCUSSION
In this report, we have observed that LPA induces two phases of PKC hydrophobic motif phosphorylation and characterized a signalling mechanism by which LPA regulates the late phase phosphorylation through its regulation of mTORC2. As depicted in Fig. 8c , LPA acts through Gα 12 to specifically activate ARAF, which in turn upregulates RFFL, leading to the polyubiquitylation and destabilization of PRR5L, a component of mTORC2 and suppressor of PKC hydrophobic motif phosphorylation. The lack of PRR5L promotes PKC-δ hydrophobic motif phosphorylation and activation by mTORC2. Thus, our study revealed a role for RFFL in mTORC2 regulation by identifying PRR5L as its substrate. RFFL is a Ring domain-containing ubiquitin E3 ligase, which is also known as rififylin and CARP2 (refs 47,48) and has only two previously reported putative substrates, p53 and RIP (refs 49,50) . There is a homologue of RFFL, RNF34 (also known as CARP1), which shares less than 50% amino acid identity with RFFL. RNF34 is unlikely to be involved in LPA and Gα 12 -mediated regulation of mTORC2, because neither Gα QL 12 nor LPA regulated its expression level in HEK293T or MEF cells (data not shown).
PRR5L and its homologue PRR5 were identified as mTORC2associated proteins [51] [52] [53] . They, unlike many of the other mTORC2 components, are not involved in the assembly of the mTORC2 complexes. Their roles in mTORC2 functions have remained unclear until recently. The finding that PRR5 deficiency seems to affect specifically SGK1 phosphorylation but not AKT or PKC hydrophobic motif phosphorylation 54 suggests that PRR5 may regulate mTORC2 activity in a substrate specific manner. Our result showing that PRR5L specifically suppresses mTORC2-mediated hydrophobic motif phosphorylation of PKC, but not AKT, bolsters the idea. Moreover, we provided a biochemical basis for the selectivity by showing that PRR5L favours the binding of mTORC2 to AKT over PKC. Although addition of recombinant PRR5L protein enhanced the substrate preference of mTORC2 for AKT, the role of PRR5L in AKT hydrophobic motif phosphorylation in vivo does not seem to be as prominent as that in PKC hydrophobic motif phosphorylation, because PRR5L knockdown or knockout had a weak effect on AKT hydrophobic motif phosphorylation. This lack of a strong effect may be because PRR5L's effect is marginalized by other regulatory factors for AKT, such as PtdIns(3,4,5)P 3 . However, we do not exclude the possibility that PRR5L may have a significant role in regulating AKT hydrophobic motif phosphorylation in a different context. Our results also suggest that PRR5 and PRR5L are not functionally redundant, at least in the regulation of PKC hydrophobic motif phosphorylation. Expression of PRR5 in Prr5 −/− ; Prr5l −/− MEFs did not suppress basal PKC hydrophobic motif phosphorylation or migration, nor did it restore the responsiveness to LPA. In addition, RFFL did not coimmunoprecipitate with or stimulate polyubiquitylation of PRR5 in overexpressed HEK293T cells (data not shown). Nevertheless, together with the selective effect of PRR5 deficiency on SGK phosphorylation 54 , we suggest that the PRR5 and PRR5L proteins may function to modulate the activity of mTORC2 in a substrate-dependent manner.
Although mTORC2 has been shown to play an important role in cell migration 13, 23, 25, 26 , the mechanisms have remained largely elusive. The stimulation of late phase PKC hydrophobic motif phosphorylation by mTORC2 may be a mechanism by which mTORC2 regulates fibroblast migration. The importance of the late phase PKC hydrophobic motif phosphorylation in cell migration was illustrated by the observation that Gα 12 deficiency, on which LPA-induced fibroblast migration depends, specifically diminished the late phase PKC hydrophobic motif phosphorylation without affecting the early phase PKC hydrophobic motif phosphorylation or activation. The fact that knockdown of PRR5L or overexpression of RFFL (which are used by Gα 12 and LPA to regulate the late phase PKC hydrophobic motif phosphorylation) stimulates cell migration supports the conclusion. Because fibroblasts migrate at a very slow pace, it is reasonable that sustained PKC activation is required for the process. A transcription and protein stability-based regulatory mechanism would be more suitable for generating sustained responses than those using Ca 2+ and lipid-derived second messengers, which are often produced in rather transient manners in cells.
Although persistent PKC-δ activation seemed to be sufficient for driving cell migration, we do not know how hydrophobic motif phosphorylation leads to PKC activation. Nor do we know how PKC-δ regulates fibroblast migration, even though some previous studies have suggested that PKC-δ plays an important role in cell migration [55] [56] [57] [58] . Cell migration is a complex process, and a large number of signalling mechanisms have been characterized for their involvement in the regulation. These signalling pathways may work in concert with others; some may be redundant of others, and some may function in a context-dependent manner to achieve optimal cell migration. It is hence important to know how PKC hydrophobic motif phosphorylation functions in relation to other signalling pathways in cell migration regulation. Furthermore, because all of the three Raf isoforms, when overexpressed, could upregulate RFFL (data not shown), it would be interesting to know whether the RFFL-PKC pathway is also used by growth factors, which activate Raf through Ras, or by activated Ras and RAF mutants, which are frequently found in cancers, to regulate cell, particularly tumour cell, migration. Finally, it is important to know how Gα 12 , but not Gα 13 , specifically activated ARAF, but not CRAF. Work is under way to investigate these questions.
METHODS
Methods and any associated references are available in the online version of the paper at www.nature.com/naturecellbiology Note: Supplementary Information is available on the Nature Cell Biology website METHODS Reagents. Protein A/G PLUS-Agarose beads were acquired from Santa Cruz, antibodies to mTOR (1:1,000, no 2972), RICTOR (mAb D16H9, 1:1,000, no 9476), MLST8 (mAb 86B8, 1:1,000, no 3274), PKC-δ (1:1,000, no 2058), AKT (1:1,000, no 9272), MARCKS (mAb D88D11, 1:1,000, 5607), ERK1 (mAb 137F5, 1:1,000, 4695), ARAF (1:1,000, no 4432), phospho-PKC(pan)(β II S660) (referred to as anti-pHM-pan-PKC, 1:1,000, no 9371), phospho-PKC-δ(Ser 643) (referred to as anti-pHM-PKC-δ (1:1,000, no 9376), phospho-MARCKS(Ser 152/156) (1:1,000, no 2741), phospho-CRAF(Ser 338) (mAb 56A6, 1:1,000, no 9427), phospho-ARAF(Ser 299) (1:1,000, no 4431) , phospho-MEK1/2(Ser 217/221) (mAb 41G9, 1:1,000, no 9154), phospho-P38(Thr 180/Tyr 182) (1:1,000, no 9211) , phospho-ERK1/2(Thr 202/Tyr 204) (mAb E10, 1:1,000, no 9106), and phospho-Akt(Ser 473) (mAb D9E, 1:1,000, no 4060) from Cell Signaling, the PRR5L antibody (1:200, no AV42637) from Sigma, Gα 12 (1:200, no sc-409) and Gα 13 (1:200, no sc-410) from Santa Cruz, Lipofectamine/Plus and Lipofectamine RNAiMax from Life Technologies, l-α-lysophosphatidic acid, cycloheximide, PD98059, U0126 and MG132 from Sigma, and bleomycin sulphate and Gö6850 from Enzo Life Sciences.
GST-PKC-δ, GST-AKT, GST-AKT-K179M, GST-PKC-δ-K376R or His-PRR5L proteins were expressed in Escherichia coli BL21 (DE3). After isopropyl-1-thioβ-d-galactopyranoside (100 µM or 1 µM) induction at 22 • C for 24 h, proteins were extracted with 0.5 mg ml −1 lysozyme in a buffer containing 20 mM Tris-HCl at pH 7.5, 300 mM NaCl, 0.1% Triton X-100 and 1 mm phenylmethylsulphonyl fluoride. Proteins were purified using glutathione-agarose or Ni-NTA agarose beads, respectively. The recombinant proteins were dialyzed in a buffer containing 20 mM Tris-HCl at pH 7.5, 100 mM NaCl, 5% glycerol.
The sequences and knockdown efficiencies of the siRNAs and shRNAs and sequences of PCR primers used in this study are listed in Supplementary Table S1 .
Cell culture and stimulation. HEK293T cells and MEFs were maintained in DMEM with 4.5 g l −1 glucose supplemented with 10% fetal bovine serum. Transient transfection was carried out using Lipofectamine and Plus, and samples were collected 24 h after transfection. Synthetic siRNA oligos (Dharmacon) were transfected using Lipofectamine RNAiMax, and samples were collected 72 h after transfection. Cells were starved overnight in DMEM without serum, followed by PBS for 60 min, before being stimulated with LPA.
Retroviruses expressing GFP, GFP-IRES-RFFL, GFP-IRES-PKC-δ, GFP-IRES-Myr-PKC-δ, GFP-IRES-Myr-PKC-δ-N, GFP-IRES-PRR5, GFP-IRES-PRR5L and GFP-IRES-Gα 12 were prepared using an MIGR retroviral vector as previously described 59 . MEFs were infected with the viruses at a multiplicity of infection of 10.
In vitro mTOR kinase assay and substrate binging assay. Immunoprecipitation of mTORC2 and the in vitro kinase assays were carried out as previously described 30 . Cell extracts harvested from a 10 cm plate were used for each immunoprecipitation condition. Cells were lysed on ice for 20 min in 1 ml of lysis buffer (40 mM HEPES at pH 7.5, 120 mM NaCl, 0.3% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulphonate (CHAPS), 1 mM EDTA, 10 mM pyrophosphate, 10 mM glycerophosphate, 50 mM NaF and EDTAfree protease inhibitors). After centrifugation, supernatants were added with the RICTOR antibody. After 90 min incubation on ice, protein A/G-PLUS beads were added, and the mixtures were incubated for another hour. Immunocomplexes were washed four times with the lysis buffer and twice with the mTORC2 kinase buffer (25 mM HEPES at pH 7.5, 100 mM potassium acetate, 2 mM MgCl 2 ) and were incubated with 200 ng His-PRR5L or BSA for 15 min at 4 • C. For the kinase assay, the above mixtures were incubated with 500 ng of kinase dead GST-PKC-δ or GST-AKT and 500 µM ATP at 37 • C for 30 min. The reactions were stopped by adding the SDS sample buffer. For the cell-free binding assay, the immunocomplexes were incubated with 500 ng of GST-PKC-δ or GST-AKT in a binding buffer (40 mM HEPES at pH 7.5, 120 mM NaCl, 0.3% CHAPS, 1 mM EDTA and EDTA-free protease inhibitors) at 4 • C for 30 min. After repeated washes with the binding buffer, the SDS sample buffer was added.
Ubiquitylation assay. Cells were harvested in a denaturing buffer (6 M guanidine-HCl, 0.1 M Na 2 HPO 4 /NaH 2 PO 4 , pH 8.0, 10 mM imidazole). The lysates were then incubated with Ni-nitrilotriacetic acid (Ni-NTA) agarose beads for 3 h, followed by four washes with the denaturing buffer and two with a low-salt buffer (25 mM Tris-HCl at pH 6.8, 20 mM imidazole). The beads were eluted by boiling in the SDS sample buffer in the presence of 200 mM imidazole. After centrifugation, the supernatants were analysed by immunoblotting.
In vitro ubiquitylation assay. For in vitro ubiquitylation assays, an ubiquitin-protein conjugation kit was acquired from BostonBiochem. Each reaction included 200 ng His-PRR5L and 5 µg GST or GST-RFFL. Reactions were incubated at 37 • C for 1 h and quenched with 10 mM EDTA.
Immunoprecipitation. Cells were lysed in a cell lysis buffer (20 mM Tris-HCl at pH 7.5, 150 mM NaCl, 1% NP-40, 5 mM EDTA, protease inhibitor cocktail, Roche's phosphatase inhibitor cocktail). After removing insoluble materials by centrifugation, immunoprecipitation was carried out by adding various antibodies (anti-HA, anti-Flag, anti-Gα 12 or Gα 13 as indicated in the figures) to supernatants. Aluminium magnesium fluoride (50 µMAlCl 3 , 10 mM MgCl 2 and 5 mM NaF) was added in immunoprecipitation of Gα subunits. Aluminium magnesium fluoride was shown to bind to GDP-bound Gα subunits to present them in active forms by mimicking the GTP-bound states, thus stabilizing the interaction of Gα subunits with their downstream targets 60, 61 .
MEF migration assays.
For the scratch migration assay, MEFs were grown to confluency in a monolayer in six-well plates. A linear gap was generated by scratching the bottoms of the wells using a sterile 200 µl pipette tip. Phase-contrast or fluorescent microscopy images were acquired at 0 and 16 h after the gaps were created. The distance migrated in 16 h by the control cells is taken as unity.
For the transwell migration assay, MEFs were serum starved overnight and resuspended in DMEM containing 0.1% FCS. These cells (5×10 4 cells per chamber) were then added to the top chambers of 24-well transwell plates, whereas the bottom chambers contain DMEM with 0.1% FCS and 5 µM LPA. The plates were incubated in a tissue culture incubator for 4 h, and the numbers of cells migrating to the bottom chambers were determined. The number of migrated control cells is taken as unity.
Cell migration was quantified using data from three independent experiments, and the data are presented as means ± s.d. (Student's t -test).
Bleomycin-induced lung fibrosis model. Gna12 −/− mice, which have been previously described 62 , together with their WT littermates, were administered with 0.05 units of bleomycin through intratracheal injection following a previously reported protocol 44, 63 . For treatment with Bortezomib or PP242, WT C56BL mice (12 weeks, female) were administered with Bortezomib (0.5 mg kg −1 , every other day, intravenously; ref. 45) or PP242 (20 mg kg −1 , daily, intraperitoneally; ref. 46) two days after bleomycin induction. Lungs were collected two weeks after bleomycin administration for histological examinations, hydroxyproline assays and western and gene expression analyses. The use and care of the mice were approved by the Institutional Animal Care and Use Committee at Yale University.
The hydroxyproline assay was carried out basically as previously described 63 . In brief, lungs were homogenized in 2.0 ml of distilled water and incubated with 125 µl of 50% trichloroacetic acid on ice for 20 min. Samples were then centrifuged, and the pellets were mixed with 1 ml of 12 N hydrochloric acid and baked at 110 • C for 14-18 h until samples were charred and dry. Next, the samples were resuspended in 2 ml of deionized water by incubating for 72 h at room temperature with intermittent vortexes. Aliquots (200 µl) of the samples were subsequently incubated with 1 ml of a solution containing 1.4% chloramine-T, 0.5 M sodium acetate and 10% isopropanol at room temperature for 20 min. Finally, 1 ml of Ehrlich's solution was added and incubated at 65 • C for 15 min. After the samples' temperature returned to room temperature, the absorbance of these samples together with the standard (trans-4-hydroxy-l-proline) at 550 nm was determined, and the hydroxyproline concentrations of these lung samples were calculated based on the hydroxyproline standard curve.
Gene expression analysis.
Total RNAs were isolated from lungs using a Polytron homogenizer in the TRIzol reagent or from cultured cells by directly adding the TRIzol reagent to the cells. They were reverse-transcripted into complementary DNAs using the iScript cDNA Synthesis Kit (Bio-Rad). qrtPCR analysis was carried out using a MyiQ rtPCR detection system (Bio-Rad) and the SYBR Green qPCR kit (Bio-Rad). GAPDH mRNA levels were used as internal controls in the qrtPCR analysis.
For the microarray gene expression analysis, HEK293T cells were treated with or without 5 µMLPA for 2 h in duplicate. Total RNAs were isolated using TRIzol, A) LPA-mediated destabilization of PRR5L depends on protein synthesis. WT MEFs were pretreated with the protein synthesis inhibitor Cycloheximide (CHX, 10 μg/ml) for 30 min before being stimulated with LPA (5 μM, 2 hrs). Quantification of immunoblots is shown. B) Knockdown of RFFL inhibits LPA-or Gα 12QL-induced PRR5L ubiquitination. HEK293T cells were cotransfected with the RFFL siRNAs and the plasmids for 72 hrs or treated with LPA (5 μM, 2 hr) as indicated. Cells were treated with MG132 for 6 hrs before LAP treatment and subjected to precipitation with Ni-NTA beads. C) RFFL interacts with PRR5L. HEK293T cells were transfected with RFFL-Flag and PRR5L-HA as indicated. The immunoprecipitation was carried out with an anti-HA antibody. D) Recombinant RFFL interacts with Recombinant PRR5L. E) RFFL-mediated PRR5L polyubiquitination depends on its Ring domain. HEK293T cells were transfected with RFFL-Flag or RFFL-ΔRF-Flag (C-terminal deletion starting at Leu-315). The next day, cells were pretreated with MG132 for 8 hrs before harvesting. Cell lysates were subjected to Ni-NTA bead pull-down and analyzed with immunoblotting. Figure S6 The Gα12-PKC pathway regulates fibroblast migration. A-B) Gα12 is required for LPA-induced fibroblast migration. Migration of WT, Gna12 -/-, Gna13 -/-MEFs and MEFs infected with retrovirus expressing GFP or GFP-IRES-Gα12 was examined using a scratch migration assays. Representative images of scratch migration assays at 0 and 16 hrs after gap creation are shown. The distance migrated in 16 hrs by cells treated with the vehicle control (Vc) is taken as 1. Cell migration was quantified from three independent experiments, and a representative one is shown. C) RFFL expression increases PKCδ HM phosphorylation in MEFs. D) PKC inhibitor Go 6850 inhibits LPA-induced cell migration. WT MEFs were pretreated with Go 6850 (1 μM) for 30 min, followed by the scratch migration assay (LPA, 5µM). Cell migration was quantified from three independent experiments, and a representative one is shown. E) PMA enhances the migration of both WT and Gna12-/-MEFs. WT and Gna12-/-MEFs were treated with PMA (100 nM) or LPA (5 µM) in the scratch migration assay. Cell migration was quantified from three independent experiments, and a representative one is shown. F) Knockdown of PKCδ inhibits LPA -induced cell migration. WT MEFs were transfected with a PKCδ siRNA (siPRKCD), followed by the scratch migration assay. The effects of PKCδ siRNAs on the levels of PKCδ, PKCα and PKCε are shown. Cell migration was quantified from three independent experiments, and a representative one is shown.
